CTX110

· CRISPR Therapeutics AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CTX110, covering 2025-10-24 to 2025-10-24. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study Evaluating CTX110 in Subjects With Relapsed or Refractory B-Cell Malignancies (CARBON) [Phase 1, Phase 2]

See pricing